problem with obsession with number of cases
pag tumaas ang cases --> media fearmongering --> people panic --> governments overreact (restrictions/lockdowns)
-
governments should drop reporting daily new cases
move on na
problem with obsession with number of cases
pag tumaas ang cases --> media fearmongering --> people panic --> governments overreact (restrictions/lockdowns)
-
governments should drop reporting daily new cases
move on na
Yung mild to critical cases sa hospitals na lang talaga concern for me. If those do not spike, herd immunity or the virus just weakened already na. Good points na yun to not resort to lockdowns.
Pero yugn facemasks sana nga huwag muna talaga tanggalin. I strongly believe na nakakatulong yun because contries na ang-spike cases mga hindi na nagsusuot ng facemasks kasi mga tao. Tutal sanay na rin naman tayo. Esp sa mga elders at may comorbid, san hindi maging complacent.
Sec. Concepcion: 27M doses ng COVID-19 vaccine, mage-expire sa June at July | SONA
hi there
how many omicron mutants do we have so far?
![]()
Last edited by uls; April 21st, 2022 at 10:12 PM.
nasa media na naman ang arch-enemy ni kagalingan, pa jab ka na daw, sayang daw yung pera eh.
Pa-inject ka daw ng 2 vaccines meant for two different variants (wild type and Beta variant)...
Preliminary results from a study testing a vaccine that targets both the original strain of the virus and the beta variant — a so-called "bivalent" vaccine — appears to produce high levels of antibodies for months that can neutralize the virus.
John Moore, an immunologist at Weil Cornell Medicine, called the results "unimpressive" in an email to NPR. "What's here is unlikely to support the rollout of this type of bivalent vaccine — the benefits would not justify the expense and hassle."
Dr. Celine Gounder, an infectious disease expert at Kaiser Health News, said the company's announcement "seems misleading" because it compared the antibodies from just two doses of the original vaccine with a third dose of the new vaccine.
Researchers are testing several new versions of Moderna's and Pfizer's vaccines to see if they provide broader protection again the omicron variant. Federal officials are hoping to see enough results by later this spring to give companies enough time to produce enough vaccines for another round of shots in the fall, when immunity from previous vaccination and infections may be waning and another surge could be looming.
puro america at cdc ito si gagoh negosyo. Jaller tingnan mo asian countriea like india indonesia bakit successful.